AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Dolutegravir Lamivudine Tenofovir Disoproxil Fumarate in Zambia
1 product registered with ZAMRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Dolutegravir Lamivudine Tenofovir disoproxil fumarate 50/300/300 mg tablet Film-coated Tablets | ZAMRA-HM-26-23 | Cipla Ltd | active | 21 Feb 2031 |
Dolutegravir Lamivudine Tenofovir Disoproxil Fumarate — ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Dolutegravir Lamivudine Tenofovir Disoproxil Fumarate, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Dolutegravir Lamivudine Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.